LOXL2 Antibody (OACD05306)

Catalog No: OACD05306

Western Blot with Mouse Recombinant LOXL2

Western Blot using Mouse Thymus Tissue

Western Blot with Mouse Recombinant LOXL2

Western Blot using Mouse Thymus Tissue

Product Info

• Predicted Species Reactivity: Human|Mouse|Rat
• Product Format: Liquid. PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
• Clonality: Polyclonal
• Isotype: IgG
• Host: Rabbit
• Application: Immunocytochemistry|Immunohistochemistry|Immunoprecipitation|Western blot
• Reconstitution and Storage: 2°C to 8°C|-20°C
• Immunogen: Recombinant LOXL2 (Pro53~Val160) expressed in E.coli
• Purification: Affinity Purified; Protein A Purified
• Concentration: 0.5 mg/ml
• Specificity: The antibody is a rabbit polyclonal antibody raised against LOXL2. It has been selected for its ability to recognize LOXL2 in immunohistochemical staining and western blotting.
• Application Info: WB: 0.5-2 ug/mL
  IHC: 5-20 ug/mL
  ICC: 5-20 ug/mL

Target Info

• Gene Symbol: Loxl2
• Gene Full Name: lysyl oxidase-like 2
• Alias Symbols: 1110004B06Rik;4930526G11Rik;9430067E15Rik;lysyl oxidase homolog 2;lysyl oxidase-like protein 2.
• NCBI Gene Id: 94352
• Protein Name: Lysyl oxidase homolog 2
• Description of Target: Mediates the post-translational oxidative deamination of lysine residues on target proteins leading to the formation of deaminated lysine (allysine) (By similarity). Acts as a transcription corepressor and specifically mediates deamination of trimethylated 'Lys-4' of histone H3 (H3K4me3), a specific tag for epigenetic transcriptional activation (By similarity). Shows no activity against histone H3 when it is trimethylated on 'Lys-9' (H3K9me3) or 'Lys-27' (H3K27me3) or when 'Lys-4' is monomethylated (H3K4me1) or dimethylated (H3K4me2) (By similarity). Also mediates deamination of methylated TAF10, a member of the transcription factor IID (TFIID) complex, which induces release of TAF10 from promoters, leading to inhibition of TFIID-dependent transcription (By similarity). LOXL2-mediated deamination of TAF10 results in transcriptional repression of genes required for embryonic stem cell pluripotency including POU5F1/OCT4, NANOG, KLF4 and SOX2 (PubMed:25959397). Involved in epithelial to mesenchymal transition (EMT) via interaction with SNAI1 and participates in repression of E-cadherin, probably by mediating deamination of histone H3 (By similarity). During EMT, involved with SNAI1 in negatively regulating pericentromeric heterochromatin transcription (By similarity). SNAI1 recruits LOXL2 to pericentromeric regions to oxidize histone H3 and repress transcription which leads to release of heterochromatin component CBX5/HP1A, enabling chromatin reorganization and acquisition of mesenchymal traits (By similarity). Interacts with the endoplasmic reticulum protein HSPA5 which activates the IRE1-XBP1 pathway of the unfolded protein response, leading to expression of several transcription factors involved in EMT and subsequent EMT induction (By similarity). When secreted into the extracellular matrix, promotes cross-linking of extracellular matrix proteins by mediating oxidative deamination of peptidyl lysine residues in precursors to fibrous collagen and elastin (By similarity). Acts as a regulator of sprouting angiogenesis, probably via collagen IV scaffolding (By similarity). Acts as a regulator of chondrocyte differentiation, probably by regulating expression of factors that control chondrocyte differentiation (PubMed:21071451).
• Uniprot ID: P58022
• Protein Accession #: NP_201582.2
• Nucleotide Accession #: NM_033325
• Molecular Weight: 81 kDa